User profiles for "author:Fabiana Rollini"

Fabiana Rollini

Post Doctoral Research Associate, University of Florida, Jacksonville
Verified email at jax.ufl.edu
Cited by 4031

International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies

DJ Angiolillo, F Rollini, RF Storey, DL Bhatt, S James… - Circulation, 2017 - Am Heart Assoc
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the treatment of choice for the
prevention of atherothrombotic events in patients with acute coronary syndromes and for …

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

M Galli, S Benenati, D Capodanno, F Franchi, F Rollini… - The Lancet, 2021 - thelancet.com
Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

D Capodanno, R Mehran, M Valgimigli… - Nature Reviews …, 2018 - nature.com
In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials

M Galli, S Benenati, F Franchi, F Rollini… - European heart …, 2022 - academic.oup.com
Aims Guidelines recommend the use of potent P2Y12 inhibitors over clopidogrel for the
reduction of ischaemic events in patients with acute coronary syndrome (ACS). However …

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

DJ Angiolillo, JA Jakubowski, JL Ferreiro… - Journal of the American …, 2014 - jacc.org
Background: Several studies have shown that patients with diabetes mellitus (DM) exhibit an
impaired response to clopidogrel. This may contribute to their increased risk of recurrent …

Switching P2Y12-receptor inhibitors in patients with coronary artery disease

F Rollini, F Franchi, DJ Angiolillo - Nature Reviews Cardiology, 2016 - nature.com
Dual antiplatelet therapy—the combination of aspirin and a P2Y 12-receptor inhibitor—is the
cornerstone of treatment of patients with acute coronary syndromes (ACS) and of those …

Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium

D Capodanno, R Mehran, MW Krucoff, U Baber… - Circulation, 2023 - Am Heart Assoc
Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or
ischemic events in patients with coronary artery disease treated with percutaneous coronary …

Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial

RF Storey, DJ Angiolillo, MP Bonaca… - Journal of the American …, 2016 - jacc.org
Abstract Background: The PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in
Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of …

Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta …

L Ortega-Paz, M Galli, D Capodanno… - European Heart …, 2022 - academic.oup.com
Background The clinical impact of different prophylactic anticoagulation regimens among
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …

Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary …

F Franchi, F Rollini, A Rivas, M Wali, M Briceno… - Circulation, 2019 - Am Heart Assoc
Background: The platelet inhibitory effects induced by oral P2Y12 receptor antagonists are
delayed in patients with ST-segment–elevation myocardial infarction undergoing primary …